Psoriatic Arthritis and Psoriasis Treatment Decision Aid

Inclusion Criteria

• •1. Age 18 years or older
• •2. Diagnosis of psoriasis (as confirmed by dermatologist) or psoriatic arthritis (as confirmed by rheumatologist)
• •3. Treated at Penn
• •In addition to the above, for the observation and implementation phases of the study:
• •4. Initiation of a new psoriasis or psoriatic arthritis treatment
• •* Biosimilars that have been approved by the FDA and available on the US market will similarly be eligible for participation
• •* Patients may be taking other traditional DMARDs.
• •* A washout period is not required.